drugset / Trial / NCT03385148

The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients

NCT03385148 ↗

Phase 0 Unknown 70 enrolled Xijing Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

The protein tyrosine kinase-7 (PTK7) is overexpressed in various types of human cancers. As a specific imaging agent of PTK7, 68Ga-Sgc8 was investigated in this study to assess its safety, biodistribution and dosimetric properties in healthy volunteers, and to preliminarily evaluate its application in colorectal patients.

Timeline

Start
2017-01-01
Primary completion
2017-12-15
Completion
2019-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-SGC8 Unknown 10 mbq —
Subject 68Ga-SGC8 Unknown 20 mbq —

Indications